SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029968
Filing Date
2019-08-07
Accepted
2019-08-07 15:24:20
Documents
73
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akca-10q_20190630.htm 10-Q 2764167
2 EX-31.1 akca-ex311_8.htm EX-31.1 18995
3 EX-31.2 akca-ex312_6.htm EX-31.2 18986
4 EX-32.1 akca-ex321_7.htm EX-32.1 10939
  Complete submission text file 0001564590-19-029968.txt   9638409

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT akca-20190630.xml EX-101.INS 2219464
6 XBRL TAXONOMY EXTENSION SCHEMA akca-20190630.xsd EX-101.SCH 77259
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20190630_cal.xml EX-101.CAL 63991
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20190630_def.xml EX-101.DEF 239570
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20190630_lab.xml EX-101.LAB 513957
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20190630_pre.xml EX-101.PRE 386248
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 191005172
SIC: 2834 Pharmaceutical Preparations